SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001438533-23-000039
Filing Date
2023-08-03
Accepted
2023-08-03 17:15:44
Documents
95
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tvtx-20230630.htm   iXBRL 10-Q 1648069
2 EX-10.2 ex06302023102.htm EX-10.2 354564
3 EX-31.1 ex06302023311.htm EX-31.1 12711
4 EX-31.2 ex06302023312.htm EX-31.2 12400
5 EX-32.1 ex06302023321.htm EX-32.1 8765
6 EX-32.2 ex06302023322.htm EX-32.2 8839
12 GRAPHIC tvtx-20230630_g1.jpg GRAPHIC 163655
  Complete submission text file 0001438533-23-000039.txt   9409710

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tvtx-20230630.xsd EX-101.SCH 57722
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tvtx-20230630_cal.xml EX-101.CAL 88144
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tvtx-20230630_def.xml EX-101.DEF 351903
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tvtx-20230630_lab.xml EX-101.LAB 798131
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tvtx-20230630_pre.xml EX-101.PRE 539956
89 EXTRACTED XBRL INSTANCE DOCUMENT tvtx-20230630_htm.xml XML 1126644
Mailing Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 888-969-7879
Travere Therapeutics, Inc. (Filer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36257 | Film No.: 231141188
SIC: 2834 Pharmaceutical Preparations